within Pharmacolibrary.Drugs.ATC.R;

model R06AD07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.013333333333333334,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0.016,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Mequitazine is a first-generation antihistamine of the phenothiazine class, primarily used for the symptomatic relief of allergic conditions such as allergic rhinitis and urticaria. It is not widely available or approved in all countries but has been used in European and Asian countries. Its use may be limited today due to availability of newer, less sedating antihistamines.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult population, as no robust clinical PK studies have been published.</p><h4>References</h4><ol><li><p>Hasegawa, T, et al., &amp; Muraoka, I (1990). Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients. <i>European journal of clinical pharmacology</i> 38(3) 255–258. DOI:<a href=&quot;https://doi.org/10.1007/BF00315026&quot;>10.1007/BF00315026</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2340844/&quot;>https://pubmed.ncbi.nlm.nih.gov/2340844</a></p></li><li><p>Kwon, OS, et al., &amp; Chung, YB (2005). Determination of mequitazine in human plasma by gas-chromatography/mass spectrometry with ion-trap detector and its pharmacokinetics after oral administration to volunteers. <i>Archives of pharmacal research</i> 28(10) 1190–1195. DOI:<a href=&quot;https://doi.org/10.1007/BF02972985&quot;>10.1007/BF02972985</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16276978/&quot;>https://pubmed.ncbi.nlm.nih.gov/16276978</a></p></li><li><p>Ylitalo, P, et al., &amp; Karma, PH (1989). Serum levels and urinary excretion of mequitazine after a single oral dose. <i>International journal of clinical pharmacology research</i> 9(5) 305–308. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2576245/&quot;>https://pubmed.ncbi.nlm.nih.gov/2576245</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R06AD07;
